Subjective cognitive impairment Fickle but fateful

David S. Knopman

doi:10.1212/WNL.0b013e31826c1bd1

Subjective cognitive impairment Fickle but fateful

David S. Knopman

Neurology

Research output: Contribution to journal › Editorial › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	1308-1309
Number of pages	2
Journal	Neurology
Volume	79
Issue number	13
DOIs	https://doi.org/10.1212/WNL.0b013e31826c1bd1
State	Published - Sep 25 2012

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e31826c1bd1

Cite this

@article{764983fc12514832bfea16ce3959a56d,

title = "Subjective cognitive impairment Fickle but fateful",

author = "Knopman, {David S.}",

note = "Funding Information: Study funding: Supported by NIH grants P50 AG16574, U01 AG06786, R01 AG41851, and R01 AG11378 , and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation . Funding Information: D.S. Knopman serves as Deputy Editor for Neurology{\textregistered}; serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals; and receives research support from the NIH. Go to Neurology.org for full disclosures.",

year = "2012",

month = sep,

day = "25",

doi = "10.1212/WNL.0b013e31826c1bd1",

language = "English (US)",

volume = "79",

pages = "1308--1309",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "13",

}

TY - JOUR

T1 - Subjective cognitive impairment Fickle but fateful

AU - Knopman, David S.

N1 - Funding Information: Study funding: Supported by NIH grants P50 AG16574, U01 AG06786, R01 AG41851, and R01 AG11378 , and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation . Funding Information: D.S. Knopman serves as Deputy Editor for Neurology®; serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals; and receives research support from the NIH. Go to Neurology.org for full disclosures.

PY - 2012/9/25

Y1 - 2012/9/25

UR - http://www.scopus.com/inward/record.url?scp=84867526875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867526875&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e31826c1bd1

DO - 10.1212/WNL.0b013e31826c1bd1

M3 - Editorial

C2 - 22914836

AN - SCOPUS:84867526875

SN - 0028-3878

VL - 79

SP - 1308

EP - 1309

JO - Neurology

JF - Neurology

IS - 13

ER -

Subjective cognitive impairment Fickle but fateful

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this